发布求助
文献互助 智能选刊 最新文献

Revue medicale de Liege最新文献

筛选
英文 中文
[TruClear™ treatment of caesarean scar pregnancy interrupted after methotrexate injection]. [TruClear™治疗甲氨蝶呤注射后中断的剖腹产疤痕妊娠]。
Revue medicale de Liege Pub Date : 2024-07-01
Aurélie Simon, Florence Hanocq, Kahy Delbecque, Frédéric Kridelka, Patricia Nervo
{"title":"[TruClear™ treatment of caesarean scar pregnancy interrupted after methotrexate injection].","authors":"Aurélie Simon, Florence Hanocq, Kahy Delbecque, Frédéric Kridelka, Patricia Nervo","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cesarean scar pregnancy is a complicated and potentially life-threatening type of ectopic pregnancy. There is no gold standard for its management. The aim is to demonstrate the efficacy and safety of treatment by hysteroscopic tissue removal system after systemic methotrexate injection.</p><p><strong>Methods: </strong>We report the case of a 27-year-old patient who had previously had a C-section and who presented herself to the emergency room with pelvic pain and metrorrhagia. The human chorionic gonadotrophin (hCG) serum level was positive. The exploration revealed an ectopic pregnancy on the cesarean scar. She benefited of 4 systemic injections of methotrexate. As the hCG became negative, endovaginal ultrasound confirmed the avascular nature of the mass. Surgical resection by mechanical morcellation hysteroscopy (TruClear™) was performed under general anaesthesia, visual control and ultrasound guidance.</p><p><strong>Results: </strong>This procedure was successful. It was an ambulatory procedure and there were neither intra- nor postoperative complications.</p><p><strong>Conclusions: </strong>To our knowledge, this is the first time in Belgium that a hysteroscopic tissue removal system procedure has been used to treat a caesarean scar pregnancy. This technique seems to be safe for both the patient and the surgeon and could become a new approach for cesarean scar pregnancy management.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 7-8","pages":"527-531"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[An unusual presentation of superior vena cava syndrome]. [上腔静脉综合征的不寻常表现]。
Revue medicale de Liege Pub Date : 2024-07-01
Gilles Terlonge, Aline Bialas, Stéphanie Charpentier, Christian Wahlen, Marc Radermecker
{"title":"[An unusual presentation of superior vena cava syndrome].","authors":"Gilles Terlonge, Aline Bialas, Stéphanie Charpentier, Christian Wahlen, Marc Radermecker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Superior vena cava syndrome (SVCS) is a clinical picture resulting from the obstruction of superior vena cava. SVCS usually causes symptoms and signs related to the head, the neck, the upper extremities and the upper thorax. We report a case of unusual clinical presentation of SVCS in a 25-year-old male patient who suffered from lymphoblastic lymphoma in childhood. Clinicians should be aware of abdominal wall presentations of SVCS especially in patients having undergone central venous catheterization, even years before. SVCS could be an emergency situation, requiring specific treatment or contraindicating surgical procedures.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 7-8","pages":"535-537"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Conservative treatment in orthopedic oncology surgery ?] [肿瘤骨科手术中的保守治疗？］
Revue medicale de Liege Pub Date : 2024-07-01
Christopher Mettlen, Olivier Galand
{"title":"[Conservative treatment in orthopedic oncology surgery ?]","authors":"Christopher Mettlen, Olivier Galand","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bone tumors are and remain rare entities in our daily hospital clinical practice. Their appearance seems anecdotal but does not remain absent. They can manifest directly (pain, redness, functional impotence, suspicious mass, etc.) or indirectly (inflammatory or paraneoplastic syndrome, profuse sweating, emaciation, etc.). The most common benign bone tumors are non-ossifying bone fibroma. Then come osteochondroma and solitary bone cysts. For malignant tumors, osteosarcomas and chondrosarcomas are at the forefront. Primary bone lymphoma accounts for less than 1 % of these. In general, lymphomatous bone lesions are frequently metastasis from primary hematological lymphoma and are therefore treated by chemotherapy. An early surgical treatment of the bone tumor is most often not mandatory and a conservative therapy may represent a valuable option.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 7-8","pages":"503-506"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Targeting dyslipidaemia in primary prevention of cardiovascular disease]. [在心血管疾病一级预防中以血脂异常为目标]。
Revue medicale de Liege Pub Date : 2024-06-01
André Scheen, Caroline Wallemacq
{"title":"[Targeting dyslipidaemia in primary prevention of cardiovascular disease].","authors":"André Scheen, Caroline Wallemacq","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Prevention of cardiovascular disease remains a key-objective from a health care point of view. The present article focuses on primary prevention, i.e. to prevent a first cardiovascular event among at-risk people. The first step is to evaluate the cardiovascular risk level (low to moderate, high, very high), which allows to fix target goals. It is especially the case regarding the management of dyslipidaemias. Lipid abnormalities are considered as a major coronary risk factor (especially, LDL or even better non-HDL cholesterol according to recent guidelines). Theoretically, it is quite easy to control this risk factor thanks to available lipid-lowering drugs, yet this goal remains insufficiently reached in clinical practice. The second step is to prescribe, in addition to life-style measures, the best pharmacological treatment. In most cases, it is a statin that should be well titrated, eventually combined with ezetimibe and/or bempedoic acid, to reach the set objectives. Finally, it is important to convince the at-risk individual by providing the valuable information regarding the benefits/risks ratio of the therapy and to verify a good drug compliance in the long run. Indeed, as dyslipidaemia is asymptomatic, people in primary prevention too easily tend to neglect (and eventually stop) the valuable therapy, also because statins have been widely (yet unfairly) criticized by some people in recent years.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"385-393"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccines in adults : an underestimated pillar of cardiovascular disease prevention]. [成人疫苗：被低估的心血管疾病预防支柱]。
Revue medicale de Liege Pub Date : 2024-06-01
Michel Moutschen
{"title":"[Vaccines in adults : an underestimated pillar of cardiovascular disease prevention].","authors":"Michel Moutschen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This brief article focuses on vaccines targeted against five infectious agents that are linked to an increased cardiovascular risk in adults: COVID-19, influenza, pneumococcus, respiratory syncytial virus, and varicella-zoster virus. The article is divided into three parts. Firstly, it outlines the mechanisms responsible for cardiovascular events that occur during and after infections. Secondly, it discusses the principles of vaccine protection in this context. The third part is dedicated to clinical studies that specifically demonstrate the cardiovascular protection afforded by the vaccines. Vaccines targeting the five aforementioned infectious agents should undoubtedly be considered key elements in the prevention of cardiovascular risk.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"277-281"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interest in the use of polygenic risk scores in breast cancer screening and preventive medicine]. [对在乳腺癌筛查和预防医学中使用多基因风险评分的兴趣]。
Revue medicale de Liege Pub Date : 2024-06-01
Julie Crèvecoeur, Elisa Docampo, Marie Martin, Vincent Bours
{"title":"[Interest in the use of polygenic risk scores in breast cancer screening and preventive medicine].","authors":"Julie Crèvecoeur, Elisa Docampo, Marie Martin, Vincent Bours","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite screening programmes, numerous clinical studies and new breast imaging techniques, breast cancer incidence for women continues to rise. The arrival of predictive and personalized medicine could clearly redefine our screening recommendations. One promising approach to improving screening would be to use tools to predict the risk of developing breast cancer, including polygenic risk scores (PRS). This approach will enable us to offer women risk-based screening by adapting the frequency, type and age of screening. This article reviews some definitions of the PRS and breast cancer screening. We also explain the risk assessment models that have been developed and the various studies underway on personalized screening.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"372-378"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Nearly one out of two deaths by cancer is avoidable ! Prevention is crucial]. [几乎每两例癌症死亡中就有一例是可以避免的！预防至关重要]。
Revue medicale de Liege Pub Date : 2024-06-01
Sylvie Streel, Renaud Louis, Guy Jerusalem
{"title":"[Nearly one out of two deaths by cancer is avoidable ! Prevention is crucial].","authors":"Sylvie Streel, Renaud Louis, Guy Jerusalem","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The observation is unequivocal: nearly half of cancer deaths could be avoided ! This statement, both alarming and hopeful, underscores the crucial importance of preventive measures in the fight against the scourge that is cancer. Indeed, if nearly half of cancer deaths are preventable, it means that it is possible to act on certain modifiable risk factors. Smoking and alcohol consumption are among the most influential behaviours in the risk of death from cancer. Similarly, overweight and obesity, considered a true pandemic, contribute significantly to the increase in the number of cancer cases over the past decade. Environmental and occupational exposure to various physical, chemical, and biological carcinogens constitutes another set of largely avoidable factors. Now, more than ever, it is imperative to intensify efforts in implementing effective prevention strategies to counter the growing burden of this disease.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"364-371"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Do drugs have a place in prevention strategies ?] [毒品在预防战略中是否占有一席之地？］
Revue medicale de Liege Pub Date : 2024-06-01
Régis Radermecker
{"title":"[Do drugs have a place in prevention strategies ?]","authors":"Régis Radermecker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>It's easy to imagine using medicines to treat or even cure an illness. For most people, however, the idea of taking one or more medicines to prevent or delay the onset of an illness or its complications seems less obvious. However, there is indeed a place for using medicines in the field of prevention. Knowing the definition of a medicine means you can immediately understand the role it can play in the field of prevention. What's more, the use of medicines should be based not only on evidence-based medicine, but also on an approach that integrates a collegial discussion with the patient, which will make it possible to discuss the expected benefits of such an approach, as well as explaining any possible side-effects. Only in this way can we expect better compliance of a person still without a disease. This article briefly summarizes the role that medicines can play in a prevention strategy.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"282-284"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Preventive effects of allergen immunotherapy to pneumallergens]. [过敏原免疫疗法对肺过敏原的预防作用]。
Revue medicale de Liege Pub Date : 2024-06-01
Nicolas Bougard, Vincent Piette, Florence Schleich, Renaud Louis
{"title":"[Preventive effects of allergen immunotherapy to pneumallergens].","authors":"Nicolas Bougard, Vincent Piette, Florence Schleich, Renaud Louis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Allergen immunotherapy is still the only curative treatment for respiratory allergies. It is based on repeated administration of allergenic extracts to sensitized patients. It can be administered either by subcutaneous or by sublingual route. The purpose of the treatment is to modulate the immune response to a specific allergen and to alter the course of the disease over a long-term period. Numerous studies and meta-analyses have demonstrated its efficacy in terms of symptoms and quality of life improvement as well as reduction of the allergic march. Indication of allergen immunotherapy includes moderate to severe allergic rhinitis and mild to moderate allergic asthma from GINA step 3. Early intervention in sensitized patients is nowadays promoted.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"405-410"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Smoking cessation rate after passage in a smoking cessation clinic in patients referred by a respiratory medicine department]. [呼吸内科转诊患者在戒烟门诊就诊后的戒烟率]。
Revue medicale de Liege Pub Date : 2024-06-01
Valérie Bonhivers, Marie Delvenne, Muriel Delvaux, Virginie Petitjean, Loïc Le Jeune, Éric Englebert, Patrizio Lancellotti, Guy Jerusalem, Renaud Louis
{"title":"[Smoking cessation rate after passage in a smoking cessation clinic in patients referred by a respiratory medicine department].","authors":"Valérie Bonhivers, Marie Delvenne, Muriel Delvaux, Virginie Petitjean, Loïc Le Jeune, Éric Englebert, Patrizio Lancellotti, Guy Jerusalem, Renaud Louis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Responsible for a significant morbidity and mortality, smoking remains a major public health issue. Smoking cessation clinics are an integral part of the fight against smoking. This retrospective study, carried out between January 2022 and January 2023 on 106 patients who attended the smoking cessation clinics in the Respiratory Department of the University Hospital of Liège, was designed to assess patient cessation rates at 6 months and 1 year, and to identify any factors predicting success or failure. Our data showed a cessation rate of 25 % at 6 months and 19 % at 1 year. Age was slightly more advanced in those who succeeded in smoking cessation at one year (p = 0.05). The obtained cessation rate strongly supports the utility of our smoking cessation clinic for patients wishing to quit smoking.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"352-356"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信